IRIS
ORIO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.500
EU - Europa 697
AS - Asia 628
AF - Africa 41
OC - Oceania 1
Totale 2.867
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.468
CN - Cina 312
SG - Singapore 254
IT - Italia 185
NL - Olanda 127
IE - Irlanda 102
FI - Finlandia 83
DE - Germania 75
SE - Svezia 61
VN - Vietnam 40
CI - Costa d'Avorio 36
CA - Canada 28
UA - Ucraina 21
GB - Regno Unito 19
IN - India 12
CZ - Repubblica Ceca 7
FR - Francia 6
MX - Messico 4
BE - Belgio 3
EG - Egitto 3
ES - Italia 3
IQ - Iraq 3
RU - Federazione Russa 3
NG - Nigeria 2
PH - Filippine 2
SA - Arabia Saudita 2
AU - Australia 1
HK - Hong Kong 1
IL - Israele 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 2.867
Salva come PNG Salva come JPEG
Città #
Chandler 297
Singapore 200
Millbury 133
Amsterdam 124
Princeton 101
Nanjing 87
Naples 87
Beijing 80
Jacksonville 75
Wilmington 49
Santa Clara 43
Ashburn 41
Dong Ket 40
Nanchang 36
Boston 34
Des Moines 26
Napoli 26
Ottawa 22
Seattle 22
Shenyang 17
Jiaxing 14
Hebei 13
Norwalk 12
Woodbridge 11
Changsha 10
Dublin 10
Tianjin 10
Dearborn 9
Falls Church 9
Boardman 8
Redwood City 8
Brno 7
Kunming 7
Buffalo 5
Lawrence 5
Pune 5
Rome 5
Yellow Springs 5
Indiana 4
Los Angeles 4
Shanghai 4
Toronto 4
Washington 4
Dallas 3
Imola 3
Kronberg 3
Lanzhou 3
Madrid 3
New York 3
Redmond 3
Zhenjiang 3
Ahmedabad 2
Ansbach 2
Changchun 2
Courcelles 2
Frattamaggiore 2
Hangzhou 2
Milan 2
Munich 2
Ningbo 2
Saint-Fons 2
Salerno 2
Springfield 2
Tappahannock 2
Ann Arbor 1
Bangalore 1
Bratislava 1
Cambridge 1
Castel San Giorgio 1
Cernusco sul Naviglio 1
Delhi 1
Duncan 1
Giugliano In Campania 1
Hefei 1
Hong Kong 1
Kolkata 1
Kumar 1
Long Beach 1
Manduria 1
Port Harcourt 1
Potenza 1
Regensburg 1
Riyadh 1
Rothesay 1
San Diego 1
San Mateo 1
San Prisco 1
Sandston 1
Simi Valley 1
Sydney 1
Taizhou 1
Torino 1
Warsaw 1
Zhengzhou 1
Totale 1.793
Salva come PNG Salva come JPEG
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 64
Cardiopulmonary impairment in young women with polycystic ovary syndrome 51
Effects of neridronate treatment in elderly women with osteoporosis 50
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 50
Influence of nutrition on somatotropic axis: Milk consumption in adult individuals with moderate-severe obesity 47
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance 47
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 46
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 44
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison 43
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 42
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 42
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 41
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 40
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome 39
Low vitamin D status and obesity: Role of nutritionist 39
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 38
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 37
Metabolic and cardiovascular consequences of polycystic ovary syndrome 37
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 37
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 37
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 37
BISPHENOL A IN POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH LIVER-SPLEEN AXIS. 37
Vitamin D and thyroid disease: To D or not to D? 37
Androgens in polycystic ovary syndrome: the role of exercise and diet 36
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 35
Cardiovascular complications of obesity in adolescents 35
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 35
Cardiovascular risk in women with polycystic ovary syndrome 35
Lifestyle changes in the management of adulthood and childhood obesity. 35
Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420-1426 35
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 34
Cardiovascular risk in women with polycystic ovary sydrome 34
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 34
Adrenocortical tumors and insulin resistance: What is the first step? 34
Endocrine Aspects of Environmental "Obesogen" Pollutants 34
Water intake keeps type 2 diabetes away? Focus on copeptin 34
Evidence for altered adipocyte function in polycystic ovary syndrome 33
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 33
Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome. 33
Nutrition, inflammation and liver-spleen axis 33
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 32
Tianeptine, an antiserotoninergic drug, increases GHRH release into the hypophyseal portal blood of the sheep 32
The integrity of the Growth Hormone and Insuline-like Growth Factor -1 axis as outcome predictor after Laparoscopic Adjustable Silicone Gastric Banding. 32
Cardiovascular complications of obesity 31
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 30
Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? 30
Vitamin D and chronic diseases: the current state of the art 30
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 29
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 29
DAI NUOVI CRITERI DIAGNOSTICI ALLE RECENTI ACQUISIZIONI TERAPEUTICHE DELLA SINDROME DELL’OVAIO POLICISTICO. 29
Effect of growth hormone on cardiac function 28
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 28
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 28
THE GOOD AND BAD EFFECTS OF STATINS ON INSULIN SENSITIVITY AND SECRETION. 28
Mechanisms in endocrinology: Vitamin D as a potential contributor in endocrine health and disease 28
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 27
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 27
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 27
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 27
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 26
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept 26
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 25
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 25
Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome 25
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors. 23
Polycystic ovary syndrome and obesity: non pharmacological approaches 23
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 23
Gut: A key player in the pathogenesis of type 2 diabetes? 23
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome 23
Failure of long-term therapy with sodium valproate in Cushing's disease. 22
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 22
STUDY OF HOMOCYSTEINE LEVELS AND C677T POLYMORPHISM OF MTHFR IN YOUNG WOMEN WITH PCOS. 22
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes 22
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 21
Endocrine disorders during the first year after autologous stem-cell transplant 21
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 21
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 20
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 20
Serum 25-Hydroxyvitamin D Levels, Phosphoprotein Enriched in Diabetes Gene Product (PED/PEA-15) and Leptin-to-Adiponectin Ratio in Women with PCOS. 20
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 19
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 19
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 19
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 18
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine 18
Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome 18
Malattie Ipotalamo Ipofisarie- Tumori ipofisari secernenti 18
LA SINDROME METABOLICA NELLA SINDROME DELL’OVAIO POLICISTICO: IL RUOLO DELL’ESERCIZIO FISICO. 18
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 18
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 18
Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome: From bench to bedside 18
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 16
Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. 16
Favourable effects of exercise-based Cardiac Rehabilitation after acute myocardial infarction on left atrial remodeling 16
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 15
Lipid profile in nonobese pregnant women with polycystic ovary syndrome: A prospective controlled clinical study 14
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS) 13
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 13
L’esercizio fisico nei soggetti obesi. 13
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. 13
Relationships between inflammatory markers, visceral fat and maximal oxygen consumption in women with polycystic ovary syndrome. 13
Totale 2.912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 0 0 9 2 12 6 12 0 2 50 48 64
2020/2021154 3 6 15 11 6 41 13 0 9 3 6 41
2021/2022614 5 3 0 6 4 58 2 11 98 28 126 273
2022/2023728 115 64 22 59 81 60 10 55 92 127 35 8
2023/2024486 24 76 118 15 16 38 3 64 3 4 77 48
2024/2025271 135 132 4 0 0 0 0 0 0 0 0 0
Totale 2.963